Eversept Partners, LP Quant / Systematic

CIK: 0001697013 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Nov 8, 2023

Total Value ($000): $184,674 (100.0% shares, 0.0% debt)

Holdings (54)

ZOGENIX INC 11.1%
Value ($000) $20,543 Shares 563,429 Est. Cost $43.68 Unrealized
GLAXOSMITHKLINE PLC 11.0%
Value ($000) $20,392 Shares 529,484 Est. Cost $39.19 Unrealized
R1 RCM INC 10.1%
Value ($000) $18,677 Shares 2,349,306 Est. Cost $5.69 Unrealized
AMARIN CORP PLC 9.3%
Value ($000) $17,195 Shares 1,263,407 Est. Cost $10.89 Unrealized
SNY SANOFI 7.2%
Value ($000) $13,294 Shares 306,242 Est. Cost $42.67 Unrealized
RADIUS HEALTH INC 4.9%
Value ($000) $9,103 Shares 552,053 Est. Cost $30.09 Unrealized
AERIE PHARMACEUTICALS INC 4.6%
Value ($000) $8,404 Shares 232,790 Est. Cost $48.65 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 3.3%
Value ($000) $6,047 Shares 36,492 Est. Cost $156.35 Unrealized +10.8%
DHR DANAHER CORP DEL 2.7%
Value ($000) $4,937 Shares 47,804 Est. Cost $87.99 Unrealized -0.1%
ABIOMED INC 2.5%
Value ($000) $4,531 Shares 13,939 Est. Cost $291.28 Unrealized
SRPT SAREPTA THERAPEUTICS INC 2.4%
Value ($000) $4,419 Shares 40,494 Est. Cost $96.51 Unrealized +29.6%
MYLAN N V 2.4%
Value ($000) $4,346 Shares 158,600 Est. Cost $27.40 Unrealized
ARGX ARGENX SE 2.0%
Value ($000) $3,672 Shares 38,224 Est. Cost $78.20 Unrealized
MRK MERCK & CO INC 1.9%
Value ($000) $3,528 Shares 45,800 Est. Cost $50.65 Unrealized +11.6%
ENSG ENSIGN GROUP INC 1.8%
Value ($000) $3,323 Shares 85,575 Est. Cost $20.90 Unrealized +82.5%
ARENA PHARMACEUTICALS INC 1.7%
Value ($000) $3,169 Shares 81,371 Est. Cost $39.50 Unrealized
TELIGENT INC NEW 1.7%
Value ($000) $3,079 Shares 2,247,476 Est. Cost $3.45 Unrealized
TESARO INC 1.4%
Value ($000) $2,673 Shares 36,000 Est. Cost $74.25 Unrealized
ABT ABBOTT LABS 1.2%
Value ($000) $2,271 Shares 31,400 Est. Cost $54.62 Unrealized +13.8%
FATE FATE THERAPEUTICS INC 1.1%
Value ($000) $2,117 Shares 165,000 Est. Cost $13.94 Unrealized 0.0%
QIAGEN NV 1.0%
Value ($000) $1,905 Shares 55,300 Est. Cost $34.45 Unrealized
ILMN ILLUMINA INC 0.8%
Value ($000) $1,544 Shares 5,148 Est. Cost $309.79 Unrealized 0.0%
GENOMIC HEALTH INC 0.8%
Value ($000) $1,537 Shares 23,866 Est. Cost $64.41 Unrealized
MYLAN N V 0.8%
Value ($000) $1,507 Shares 55,000 Est. Cost $27.40 Unrealized
DECIPHERA PHARMACEUTICALS IN 0.8%
Value ($000) $1,463 Shares 69,700 Est. Cost $20.99 Unrealized
APLS APELLIS PHARMACEUTICALS INC 0.8%
Value ($000) $1,410 Shares 106,880 Est. Cost $22.43 Unrealized -31.6%
LOXO ONCOLOGY INC 0.8%
Value ($000) $1,401 Shares 10,000 Est. Cost $140.07 Unrealized
BIOSPECIFICS TECHNOLOGIES CO 0.7%
Value ($000) $1,333 Shares 22,000 Est. Cost $58.49 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 0.7%
Value ($000) $1,323 Shares 163,959 Est. Cost $5.11 Unrealized +52.1%
XENE XENON PHARMACEUTICALS INC 0.7%
Value ($000) $1,294 Shares 205,104 Est. Cost $11.59 Unrealized -23.3%
ARRAY BIOPHARMA INC 0.7%
Value ($000) $1,288 Shares 90,412 Est. Cost $13.60 Unrealized
FOAMIX PHARMACEUTICALS LTD 0.6%
Value ($000) $1,058 Shares 294,660 Est. Cost $5.36 Unrealized
AFFIMED N V 0.6%
Value ($000) $1,044 Shares 335,774 Est. Cost $2.11 Unrealized
CTRE CARETRUST REIT INC 0.5%
Value ($000) $956 Shares 51,264 Est. Cost $16.94 Unrealized
ASND ASCENDIS PHARMA A S 0.5%
Value ($000) $956 Shares 15,254 Est. Cost $55.41 Unrealized
TRICIDA INC 0.5%
Value ($000) $956 Shares 40,522 Est. Cost $27.73 Unrealized
ARQULE INC 0.5%
Value ($000) $955 Shares 344,618 Est. Cost $5.09 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 0.5%
Value ($000) $861 Shares 42,301 Est. Cost $70.81 Unrealized -57.6%
SAGE THERAPEUTICS INC 0.4%
Value ($000) $792 Shares 8,271 Est. Cost $159.04 Unrealized
ELV ANTHEM INC 0.3%
Value ($000) $604 Shares 2,300 Est. Cost $211.75 Unrealized +18.1%
FOLD AMICUS THERAPEUTICS INC 0.3%
Value ($000) $601 Shares 62,750 Est. Cost $13.98 Unrealized -21.4%
NTRA NATERA INC 0.3%
Value ($000) $552 Shares 39,539 Est. Cost $18.26 Unrealized 0.0%
CNC CENTENE CORP DEL 0.3%
Value ($000) $496 Shares 4,300 Est. Cost $52.13 Unrealized +28.4%
ALBIREO PHARMA INC 0.2%
Value ($000) $442 Shares 18,029 Est. Cost $32.57 Unrealized
DICERNA PHARMACEUTICALS INC 0.2%
Value ($000) $439 Shares 41,074 Est. Cost $12.25 Unrealized
LAB FLUIDIGM CORP DEL 0.2%
Value ($000) $435 Shares 50,455 Est. Cost $7.79 Unrealized 0.0%
CYMABAY THERAPEUTICS INC 0.2%
Value ($000) $371 Shares 47,096 Est. Cost $13.42 Unrealized
INVACARE CORP 0.2%
Value ($000) $318 Shares 73,902 Est. Cost $16.67 Unrealized
SEASPINE HLDGS CORP 0.2%
Value ($000) $282 Shares 15,459 Est. Cost $10.12 Unrealized
TGTX TG THERAPEUTICS INC 0.1%
Value ($000) $267 Shares 65,000 Est. Cost $12.78 Unrealized -61.1%
OPIANT PHARMACEUTICALS INC 0.1%
Value ($000) $201 Shares 13,901 Est. Cost $14.45 Unrealized
AQUINOX PHARMACEUTICALS INC 0.1%
Value ($000) $159 Shares 73,717 Est. Cost $2.16 Unrealized
EPIZYME INC 0.1%
Value ($000) $157 Shares 25,449 Est. Cost $17.75 Unrealized
CONFORMIS INC 0.0%
Value ($000) $49 Shares 136,851 Est. Cost $1.18 Unrealized